Form 8-K - Current report:
SEC Accession No. 0001493152-25-020881
Filing Date
2025-11-05
Accepted
2025-11-05 16:21:29
Documents
13
Period of Report
2025-11-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41004
  Complete submission text file 0001493152-25-020881.txt   249764

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ptix-20251103.xsd EX-101.SCH 3789
3 XBRL DEFINITION FILE ptix-20251103_def.xml EX-101.DEF 26650
4 XBRL LABEL FILE ptix-20251103_lab.xml EX-101.LAB 36748
5 XBRL PRESENTATION FILE ptix-20251103_pre.xml EX-101.PRE 25274
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5767
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-12555 | Film No.: 251454414
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)